Cargando…

Tuberculosis control, and the where and why of artificial intelligence

Countries aiming to reduce their tuberculosis (TB) burden by 2035 to the levels envisaged by the World Health Organization End TB Strategy need to innovate, with approaches such as digital health (electronic and mobile health) in support of patient care, surveillance, programme management, training...

Descripción completa

Detalles Bibliográficos
Autores principales: Doshi, Riddhi, Falzon, Dennis, Thomas, Bruce V., Temesgen, Zelalem, Sadasivan, Lal, Migliori, Giovanni Battista, Raviglione, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478795/
https://www.ncbi.nlm.nih.gov/pubmed/28656130
http://dx.doi.org/10.1183/23120541.00056-2017
_version_ 1783245025794064384
author Doshi, Riddhi
Falzon, Dennis
Thomas, Bruce V.
Temesgen, Zelalem
Sadasivan, Lal
Migliori, Giovanni Battista
Raviglione, Mario
author_facet Doshi, Riddhi
Falzon, Dennis
Thomas, Bruce V.
Temesgen, Zelalem
Sadasivan, Lal
Migliori, Giovanni Battista
Raviglione, Mario
author_sort Doshi, Riddhi
collection PubMed
description Countries aiming to reduce their tuberculosis (TB) burden by 2035 to the levels envisaged by the World Health Organization End TB Strategy need to innovate, with approaches such as digital health (electronic and mobile health) in support of patient care, surveillance, programme management, training and communication. Alongside the large-scale roll-out required for such interventions to make a significant impact, products must stay abreast of advancing technology over time. The integration of artificial intelligence into new software promises to make processes more effective and efficient, endowing them with a potential hitherto unimaginable. Users can benefit from artificial intelligence-enabled pattern recognition software for tasks ranging from reading radiographs to adverse event monitoring, sifting through vast datasets to personalise a patient's care plan or to customise training materials. Many experts forecast the imminent transformation of the delivery of healthcare services. We discuss how artificial intelligence and machine learning could revolutionise the management of TB.
format Online
Article
Text
id pubmed-5478795
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-54787952017-06-27 Tuberculosis control, and the where and why of artificial intelligence Doshi, Riddhi Falzon, Dennis Thomas, Bruce V. Temesgen, Zelalem Sadasivan, Lal Migliori, Giovanni Battista Raviglione, Mario ERJ Open Res Review Countries aiming to reduce their tuberculosis (TB) burden by 2035 to the levels envisaged by the World Health Organization End TB Strategy need to innovate, with approaches such as digital health (electronic and mobile health) in support of patient care, surveillance, programme management, training and communication. Alongside the large-scale roll-out required for such interventions to make a significant impact, products must stay abreast of advancing technology over time. The integration of artificial intelligence into new software promises to make processes more effective and efficient, endowing them with a potential hitherto unimaginable. Users can benefit from artificial intelligence-enabled pattern recognition software for tasks ranging from reading radiographs to adverse event monitoring, sifting through vast datasets to personalise a patient's care plan or to customise training materials. Many experts forecast the imminent transformation of the delivery of healthcare services. We discuss how artificial intelligence and machine learning could revolutionise the management of TB. European Respiratory Society 2017-06-21 /pmc/articles/PMC5478795/ /pubmed/28656130 http://dx.doi.org/10.1183/23120541.00056-2017 Text en The content of this work is © the authors or their employers. Design and branding are © ERS 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Review
Doshi, Riddhi
Falzon, Dennis
Thomas, Bruce V.
Temesgen, Zelalem
Sadasivan, Lal
Migliori, Giovanni Battista
Raviglione, Mario
Tuberculosis control, and the where and why of artificial intelligence
title Tuberculosis control, and the where and why of artificial intelligence
title_full Tuberculosis control, and the where and why of artificial intelligence
title_fullStr Tuberculosis control, and the where and why of artificial intelligence
title_full_unstemmed Tuberculosis control, and the where and why of artificial intelligence
title_short Tuberculosis control, and the where and why of artificial intelligence
title_sort tuberculosis control, and the where and why of artificial intelligence
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478795/
https://www.ncbi.nlm.nih.gov/pubmed/28656130
http://dx.doi.org/10.1183/23120541.00056-2017
work_keys_str_mv AT doshiriddhi tuberculosiscontrolandthewhereandwhyofartificialintelligence
AT falzondennis tuberculosiscontrolandthewhereandwhyofartificialintelligence
AT thomasbrucev tuberculosiscontrolandthewhereandwhyofartificialintelligence
AT temesgenzelalem tuberculosiscontrolandthewhereandwhyofartificialintelligence
AT sadasivanlal tuberculosiscontrolandthewhereandwhyofartificialintelligence
AT migliorigiovannibattista tuberculosiscontrolandthewhereandwhyofartificialintelligence
AT raviglionemario tuberculosiscontrolandthewhereandwhyofartificialintelligence